Rejuvenate Bio secures $4M to advance gene therapy for a devastating heart disease
BioProcess International - 27-Aug-2024A promising one-time treatment approach for arrhythmogenic cardiomyopathy
Rejuvenate Bio
Company delivering age-reversing gene therapies for animals
At Rejuvenate Bio, we aspire to treat aging and age-related diseases afflicting animals, such as MVD. We launched out of George Church's lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University. Our targeted gene therapies treat pets and are directed at curing specific disease states associated with old age. These therapies have the potential to extend overall health and lifespan.
Visit website: https://www.rejuvenatebio.com/
Details last updated 21-Nov-2019
Rejuvenate Bio News
The remaining lifespan of old mice, equivalent to a human age of 77 years, doubled
Live Forever Club - 25-Feb-2024Therapy used OSKM genes to potentially extend lifespan and reverse ageing signs
Rejuvenate Bio partners with animal company to develop gene therapy for canine osteoarthritis
Biospace - 14-Feb-2024Single dose injection targets root causes, offering long-term relief & improved quality of life
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Partial Cellular Reprogramming in Very Old Mice Doubles Remaining Life Expectancy
Live Forever Club - 03-Feb-2023Shown to work at a cellular level in humans, too, so a therapeutic could be developed soon
Display all news
Rejuvenate Bio is also referenced in the following:
Longevity Cafe : Cellular Level Rejuvenation - Coffee and Chat
25-Feb-2023
The club's Longevity Cafe Meetup group will be discussing the latest research by Rejuvenate Bio (FREE)
People at Rejuvenate Bio
